Marksans Pharma consolidated net profit rises 97.60% in the September 2018 quarter
Sales decline 1.74% to Rs 269.04 crore
Net profit of Marksans Pharma rose 97.60% to Rs 20.57 crore in the quarter ended September 2018 as against Rs 10.41 crore during the previous quarter ended September 2017. Sales declined 1.74% to Rs 269.04 crore in the quarter ended September 2018 as against Rs 273.81 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales269.04273.81 -2 OPM %13.808.98 -PBDT33.2621.55 54 PBT27.7214.57 90 NP20.5710.41 98Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 14 2018 | 4:20 PM IST